Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market.
Lithium has been used for over half a century for the treatment of bipolar disorder as the archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in this role. Despite this, the specific mechanisms by which lithium exerts its mood-stabilizing effects are not well understood.
Lithium is a prescription medication used for the management of bipolar disorder. It is the most commonly prescribed mood stabilizer to treat both manic and depressive episodes. The drug exerts its action by blocking chemicals in the nerves and muscles that cause the manifestation of bipolar disorder. Lithium may produce many side effects including those that affect the cardiovascular system.